Meena 1.2 web.jpg

Meena Dam


Meena has over 25 years of experience in project management, strategy and partnership development, data management and operations leadership in the CRO, medical device and pharmaceutical industry. Before joining ClinSmart, she served as Senior Project Manager at Bio-Imaging Technologies, now BioClinica.

Meena has a balanced perspective on the industry having held several positions with both big pharma and specialty start-up companies.

She is heavily involved in her community and abroad and continues to direct Bengali Kids of Princeton Area, a non-profit education and cultural society founded by her children. Meena has a passion for mentoring and character building and often accompanies area youth as far as Mother Theresa‚Äôs Orphanage in India to help develop values. 

Christina Tay

Christina Tay, MD

Safety Officer

Dr. Christina Tay joined ClinSmart in 2014 with over 17 years of medical expertise and clinical research experience. Through the years Christina has worked directly with Investigators and Sponsors by assuring regulatory compliance, performing safety assessments, and leading clinical project teams.

Dr. Tay has fostered a culture of excellence, by quickly identifying and resolving issues, training clinical staff members and providing prompt turnaround Sponsors have come to appreciate from working with ClinSmart.

Christina Tay is an animal lover and adopted her most recent cat from the local animal shelter.  She is an avid traveler and has visited over 20 countries.

James Perhach

James L. Perhach, PhD, FCP

Director, Clinical Development & Research

James Perhach is an accomplished clinical research professional and Fellow of the American College of Clinical Pharmacology with over 25 years of experience in drug development and approval in neurotherapeutics, analgesics, respiratory and other areas including commercial support programs.  Prior to joining ClinSmart he developed, implemented and monitored yearly clinical trial budgets of over $100 million.   

Dr. Perhach continues to focus on optimizing clinical development strategy to provide evidence of efficacy to support continued clinical development and demonstrate commercial value of the product at the time of submission. 

Jim is an avid Pitt fan, and you can often find him cheering for his favorite team.  He also enjoys the finer things in life like sketching and painting with an iPad.

Raymond E. Tobey, MD

Chief Medical Officer

Michael F. Miller, PhD

Director, Biostatistical & Quantitative Analysis

Robert Hand

Medical Writer

John E. Higson, MBA

Director, Project Management